7 ways clinicians can help reduce opioid misuse and addiction
(By Brian Zimmerman for Becker’s Hospital Review) Solving the nation’s opioid overdose and addiction crisis will require robust efforts from
Read More
Cancer patients prioritize physician relationships over quality and safety, study finds
(By Mackenzie Bean for Becker’s Hospital Review) Oncology patients and their families prioritize positive clinician relationships over quality and safety
Read MoreHouse Reps. request HHS briefing on Petya attacks related to drug industry
(By Julie Spitzer for Becker’s Hospital Review) Top House Republicans on the House Energy and Commerce Committee are urging HHS
Read MoreWhat every state stands to gain or lose under Graham-Cassidy, according to CMS
(By Leo Vartorella for Becker’s Hospital Review) The Graham-Cassidy healthcare proposal would roll back Medicaid expansion and federal premium subsidies,
Read MoreOvershadowed by Obamacare debate, payments to safety net hospitals at risk of expiring
(By Max Blau for STAT) ATLANTA — Drive around this city long enough, and you’ll see the billboards that have
Read MoreHHS hints at major changes to Medicare that could mean higher costs for patients
(By Erin Mershon for STAT) WASHINGTON — The Trump administration is signaling it will pursue significant changes to Medicare that
Read MoreTo Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
(By Chad Terhune for California Healthline produced by Kaiser Health News) Seeking to prevent superbug outbreaks, federal health officials said
Read MoreNarrow Networks Get Even Tighter When Shopping For Mental Health Specialists
(By Michelle Andrews for Kaiser Health News) If you’ve got a plan offered on the federal health law’s insurance marketplace
Read MoreHHS ups reimbursement to 110% of Medicare for hospitals treating patients affected by Hurricane Irma
(By Morgan Haefner for Becker’s Hospital Review) For the first time since an earthquake devastated Haiti in 2010, HHS activated a national
Read MoreAlnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines
(By Adam Feuerstein for STAT) The age of RNA interference drugs has arrived. Alnylam Pharmaceuticals announced positive results Wednesday from
Read More